Building resilience in America's supply chain of care

We’ve been taking bold steps to build our resilience right here in the U.S.

Drug shortages are problematic for patients, providers and manufacturers. At Fresenius Kabi, our purpose is to help patients gain better access to the life-saving treatments they need – when and where they need them most. We are dedicated to doing more in America to expand and enhance our production and supply chain network. But we realize that solving the problem of drug shortages will require both individual and collective actions. Unwinding the conditions that contribute to shortages will require new ways of thinking and collaborating. It will also require that each participant in the supply chain of care take steps to improve their own resilience.  

With that in mind, we’ve been taking bold steps to build our resilience right here in the U.S.